GB201021794D0 - Treatment and diagnosis of behavioural disorders - Google Patents
Treatment and diagnosis of behavioural disordersInfo
- Publication number
- GB201021794D0 GB201021794D0 GBGB1021794.1A GB201021794A GB201021794D0 GB 201021794 D0 GB201021794 D0 GB 201021794D0 GB 201021794 A GB201021794 A GB 201021794A GB 201021794 D0 GB201021794 D0 GB 201021794D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- diagnosis
- behavioural
- behavioural disorders
- eif4e
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention concerns the identification of a novel drug target for use in the treatment of behavioural dis order, hi particular, the invention provides compounds capable of modulating the expression, function and/or activity of eIF4E, for use in treating a behavioural disorder as well as methods of identifying the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0809821A GB0809821D0 (en) | 2008-05-30 | 2008-05-30 | Treatment and diagnosis of behavioural disorders |
PCT/GB2009/001367 WO2009144480A1 (en) | 2008-05-30 | 2009-05-29 | Treatment and diagnosis of behavioural disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201021794D0 true GB201021794D0 (en) | 2011-02-02 |
GB2473575A GB2473575A (en) | 2011-03-16 |
GB2473575B GB2473575B (en) | 2013-02-20 |
Family
ID=39637839
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0809821A Ceased GB0809821D0 (en) | 2008-05-30 | 2008-05-30 | Treatment and diagnosis of behavioural disorders |
GB1021794.1A Expired - Fee Related GB2473575B (en) | 2008-05-30 | 2009-05-29 | Diagnosis of autism |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0809821A Ceased GB0809821D0 (en) | 2008-05-30 | 2008-05-30 | Treatment and diagnosis of behavioural disorders |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB0809821D0 (en) |
WO (1) | WO2009144480A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110166029A1 (en) | 2009-09-08 | 2011-07-07 | David Michael Margulies | Compositions And Methods For Diagnosing Autism Spectrum Disorders |
US10509045B2 (en) | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
US10940161B2 (en) | 2016-04-04 | 2021-03-09 | University Of Florida Research Foundation, Incorporated | Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation |
WO2018195110A1 (en) | 2017-04-17 | 2018-10-25 | University Of Florida Research Foundation, Incorporated | Regolation of ran translation by pkr and eif2a-p pathways |
AU2018342105B2 (en) | 2017-09-26 | 2023-11-16 | University Of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
US20240052004A1 (en) * | 2019-10-04 | 2024-02-15 | Yale University | Targeting cap-dependent translation to reduce seizures in mtor disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007094755A2 (en) * | 2005-02-04 | 2007-08-23 | Massachusetts Institute Of Technology | Compositions and methods for modulating cognitive function |
-
2008
- 2008-05-30 GB GB0809821A patent/GB0809821D0/en not_active Ceased
-
2009
- 2009-05-29 GB GB1021794.1A patent/GB2473575B/en not_active Expired - Fee Related
- 2009-05-29 WO PCT/GB2009/001367 patent/WO2009144480A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB0809821D0 (en) | 2008-07-09 |
GB2473575B (en) | 2013-02-20 |
GB2473575A (en) | 2011-03-16 |
WO2009144480A1 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011038210A3 (en) | Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity | |
UA98629C2 (en) | Compounds and methods for kinase modulation | |
UA107667C2 (en) | Medical compounds stimulating activity of pyruvate kinase m2, compositions on their basis and use in the treatment of cancer | |
WO2010009342A3 (en) | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | |
AU2011328009A8 (en) | Compounds and methods for treating pain | |
BRPI0813311A2 (en) | COMPOUND, METHODS FOR MODULATING THE ACTIVITY OF A PROTEIN KINASE AND FOR TREATING CANCER IN AN INDIVIDUAL AND PHARMACEUTICAL COMPOSITION. | |
UA109878C2 (en) | Isoquinolinone derivatives, pharmaceutical composition based on them (variants), and method of treating diseases (variants) | |
MX2008006076A (en) | Methods, compositions, and kits for the treatment of medical conditions. | |
WO2014035140A3 (en) | Compounds and compositions for modulating histone methyltransferase activity | |
EP4295912A3 (en) | Compounds and methods for kinase modulation, and indications therefor | |
WO2012040499A3 (en) | Metabolic inhibitors | |
TN2011000176A1 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
WO2008086025A3 (en) | Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity | |
GB201021794D0 (en) | Treatment and diagnosis of behavioural disorders | |
BR112018007026A2 (en) | compound, gaba-at activity modulation method, dopamine level modulation method, substance dependence treatment method, ornithine aminotransferase activity modulation method, ornithine aminotransferase activity reduction method expressed by a human hepatocellular carcinoma and method for treating psychological and neurological disorders | |
UY33276A (en) | AMINO-OXAZINES AND AMINO-DIHYDROTIAZINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | |
WO2010034015A3 (en) | Modulating the alternative complement pathway | |
WO2012009402A3 (en) | Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg | |
EP3712264A8 (en) | Cystathionine beta-synthase enzyme for treatment of homocystinuria | |
WO2009015369A3 (en) | Isophthalamide derivatives inhibiting beta-secretase activity | |
MY155340A (en) | Use of cathepsin c | |
WO2011097522A3 (en) | Combination methods for treatment of disease | |
WO2008155390A3 (en) | Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. | |
MX2009009693A (en) | Methods of activating irs-1 and akt. | |
NZ606276A (en) | Fastening Means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20150529 |